Name: UMIN ID:
Unique ID issued by UMIN | UMIN000048296 |
---|---|
Receipt number | R000054917 |
Scientific Title | Phase II clinical trial to evaluate the safety and efficacy of particle radiotherapy preceded atezolizumab plus bevacizumab treatment in patients with unresectable multiple hepatocellular carcinoma |
Date of disclosure of the study information | 2022/09/01 |
Last modified on | 2023/07/07 09:07:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2022/07/06 10:20:59 | ||
2 | Update | 2023/01/06 12:49:37 | Anticipated trial start date |
|
3 | Update | 2023/07/07 09:07:07 | Recruitment status Date of IRB |